GLORIA™-AF stands for "Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation."
The GLORIA™-AF Registry Program is a large, international, prospective registry progam designed to characterize newly diagnosed patients with non-valvular atrial fibrillation at risk for stroke in different regions of the world.
Latest news about the GLORIA™-AF registry will be posted here.
Information regarding the design and rationale of GLORIA™-AF has been published.
Reference: Huisman, M.V. et al. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation:
A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Am Heart J. 2014;167:329-34.
This international website is dedicated to investigators and study staff of the GLORIA™-AF Registry Program as well as the general public including physicians, patients and media. On this website you will find helpful information about the GLORIA™-AF Registry, including the login access to the GLORIA™-AF Electronic Data Capture System for participating investigators. In addition, the latest registry news, disease information, publications and useful links for medical staff and patients can be found here.